CHiRP Study: Utilizing RaDaR® for recurrence monitoring in HR+, HER2- breast cancer
Watch this short video discussing the CHiRP Study, which evaluated circulating tumor DNA (ctDNA) and late recurrence in high-risk hormone receptor positive, HER2-negative breast cancer.
USCAP 2022 Exhibitor Seminar: NGS and Hematologic Malignancies
Hematologic malignancies pose many challenges – from diagnostic subtyping, to risk stratification and even in therapy selection.
The Breakroom Video Series
Ep. 1 Ch. 1 - Addressing issues in lung cancer biomarker testing.
The Breakroom Video Series
Ep. 1 Ch. 3 - What we need to know about EGFR exon 20 insertion mutations.
The Breakroom Video Series
Ep. 1 Ch. 4 - Improving detection of EGFR insertion mutation using NGS
The Breakroom Video Series
Ep. 1 Ch. 5 - Why oncology is a team sport – and how we can be better players